MIRA INFORM REPORT

 

 

Report No. :

337400

Report Date :

20.08.2015

 

IDENTIFICATION DETAILS

 

Name :

CRESCENT THERAPEUTICS LIMITED (w.e.f 27.03.2002)

 

 

Formerly Known As :

CRESCENT THERAPEUTICS PRIVATE LIMITED

 

 

Registered Office :

H. No 4-7-11/4/B, Crescent Towers, Raghavendra Nagar, Nacharam, Hyderabad – 500076, Telangana

Tel. No.:

91-40-27178843

 

 

Country :

India

 

 

Financials (as on) :

31.03.2014

 

 

Date of Incorporation :

21.11.2000

 

 

Com. Reg. No.:

035708

 

 

Capital Investment / Paid-up Capital :

Rs. 41.579 Million

 

 

CIN No.:

[Company Identification No.]

U29297TG2000PLC035708

 

 

IEC No.:

Not Available

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

Not Available

 

 

PAN No.:

[Permanent Account No.]

AABCC9421B

 

 

Legal Form :

A Closely Held Public Limited Liability Company

 

 

Line of Business :

Manufacturer of Pharmaceutical Products, Pharmaceuticals Formulations, Mask, Disposable Items, etc.

 

 

No. of Employees :

200 (Approximately)

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba (47)

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Status :

Satisfactory

 

 

Payment Behaviour :

Usually Correct

 

 

Litigation :

Clear

 

 

Comments :

Crescent Therapeutics Limited was incorporated on 21st November, 2000 it is established company having satisfactory track record.

 

The company reported an operating income and net profit of Rs.463.300 Million and Rs.15.200 Million respectively in FY2014 as against an operating income and net profit of Rs.304.100 Million and Rs.11.900 Million respectively in FY2013.

 

The rating take into account on company experienced promoters and qualified professional management in the pharmaceutical industry and diversified product mix with drugs covering several therapeutic segments. The ratings also factor in comfortable capital structure with gearing of 0.84 times in FY14.

 

Moreover, the company has constructed plant with WHO-GMP standards and having GMP certificate.

 

Trade relations are reported as fair. Business is active. Payment terms are reported to be usually correct.

 

The company can be considered normal for business dealings at its usual trade terms and conditions. 

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – March 31, 2015

 

Country Name

Previous Rating

(31.12.2014)

Current Rating

(31.03.2015)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

EXTERNAL AGENCY RATING

 

Rating Agency Name

CARE

Rating

Long term Bank Facilities=B+

Rating Explanation

Risk-prone-credit-quality and carries very high credit risk

Date

May, 2015

 

 

Rating Agency Name

CARE

Rating

Short term Bank Facilities=A4

Rating Explanation

Minimal degree of safety and very high credit risk

Date

May, 2015

 

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 


 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2013.

 

 

INFORMATION PARTED BY

 

Name :

Mr. Shiv Thakur

Designation :

Accounts Department

Contact No.:

91-1795-271246

Date :

19.08.2015

 

 

LOCATIONS

 

Registered Office :

H. No 4-7-11/4/B, Crescent Towers, Raghavendra Nagar, Nacharam, Hyderabad – 500076, Telangana, India

Tel. No.:

91-40-27178843/ 27170830/ 27171067

Fax No.:

Not Available

E-Mail :

vpca@crescenttherapeutics.org

finance@crescenttherapeutics.org

Website :

http://www.crescenttherapeutics.org

Location :

Owned

Locality :

Commercial

 

 

Factory :

Khasra No 587/588, Village Khunjal, Jharmajri, Baddi, Nalagarh District Solan – 173205, Himachal Pradesh, India

Tel. No.:

91-91-1795-271246

E-Mail :

skjctl@yahoo.com

 

 

DIRECTORS

 

AS ON 26.09.2014

 

Name :

Mr. Shaik Janimiya

Designation :

Managing Director

Address :

H. No: 4-10-119/S-1, HMT Nagar, Street No:11, Nacharam, Hyderabad – 500076, Andhra Pradesh, India 

Date of Birth/Age :

31.08.1957

Date of Appointment :

08.03.2007

DIN No.:

01089672

Other Directorship :

S.No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Company/ LLP Status

Defaulting status

1

U29297TG2000PLC035708

CRESCENT THERAPEUTICS LIMITED

Managing director

08-03-2007

27-03-2002

Active

NO

2

U24232TG2010PTC070991

CRESCENT FORMULATIONS PRIVATE LIMITED

Director

28-10-2010

28-10-2010

Active

NO

 

 

Name :

Mrs. Shaik Thahera

Designation :

Director

Address :

H. No: 4-10-119/S-1, Plot No 36, HMT Nagar, Street No:11, Nacharam, Hyderabad – 500076, Andhra Pradesh, India 

Date of Birth/Age :

18.05.1969

Date of Appointment :

27.03.2002

DIN No.:

01089807

Other Directorship :

S.No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Company/ LLP Status

Defaulting status

1

U29297TG2000PLC035708

CRESCENT THERAPEUTICS LIMITED

Director

27-03-2002

27-03-2002

Active

NO

2

U24232TG2010PTC070991

CRESCENT FORMULATIONS PRIVATE LIMITED

Director

28-10-2010

28-10-2010

Active

NO

 

 

Name :

Mr. Yeluripati Venkata Vijaya Bhaskara Ramabhadra Chainulu

Designation :

Director

Address :

1-10-25,  Block No 95, St No 3, Ashoknagar, Hyderabad - 500020, Andhra Pradesh, India 

Date of Birth/Age :

01.11.1941

Date of Appointment :

29.09.2007

DIN No.:

02611623

Other Directorship :

S.No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Company/ LLP Status

Defaulting status

1

U29297TG2000PLC035708

CRESCENT THERAPEUTICS LIMITED

Director

29-09-2007

25-01-2007

Active

NO

 

 

Name :

Mr. Karakavenkata Venugopalakrishna Rao

Designation :

Director

Address :

23-195, NUZVID, Krishna – 521201, Andhra Pradesh, India 

Date of Birth/Age :

01.06.1963

Date of Appointment :

29.09.2007

DIN No.:

02611732

Other Directorship :

S.No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Company/ LLP Status

Defaulting status

1

U29297TG2000PLC035708

CRESCENT THERAPEUTICS LIMITED

Director

29-09-2007

25-01-2007

Active

NO

 

 

KEY EXECUTIVES

 

Name :

Mr. Shiv Thakur

Designation :

Accounts Department

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

AS ON 26.09.2014

 

Names of Shareholders

No. of Shares

 

SK. Janimiya

3080000

SK. Thahera

680000

Y.V.V.B.R. Chainulu

12305

K.V.V.G. Krishna Rao

100

SK. Javeed

227395

A. Parameshwar Rao

100

MD. Moinuddin

100

Y. Rama Rao

157900

Total

4157900

 

 

AS ON 26.09.2014

 

Equity Share Breakup

Percentage of Holding

Category

 

Directors or relatives of directors

95.90

Other top fifty shareholders

4.10

Total

100.00

 


 

BUSINESS DETAILS

 

Line of Business :

Manufacturer of Pharmaceutical Products, Pharmaceuticals Formulations, Mask, Disposable Items, etc.

 

 

Brand Names :

--

 

 

Agencies Held :

--

 

 

Exports :

 

Products :

Pharmaceutical Product

Countries :

·         Sri Lanka

·         Kenya

 

 

Imports :

 

Products :

--

Countries :

--

 

 

Terms :

 

Selling :

Advance Payment, Cheque and Credit (60 days and 90 days)

 

 

Purchasing :

Advance Payment, Cheque and Credit (60 days and 90 days)

 

PRODUCTION STATUS: NOT AVAILABLE

 

 

GENERAL INFORMATION

 

Suppliers :

Reference:

Everst Organise Limited

Name of the Person (Designation):

Mr. Venkat (Marketing Executive)

Contact Number:

91-40-40040783

Since how long known:

10 Years

Maximum limit dealt:

Rs. 4.000 Million (Monthly)

Experience:

Product Quality

Delivery Behaviour

Overall

Good

Good

Good

Remark

We had a word with Mr. Venkat (Marketing Executive) he inform that they are satisfy with there payment behaviour. Overall Subject company have very good track record with their supplier.

 

 

Customers :

Wholesalers, Retailers and End Users

 

Reference:

Alembic Pharmaceuticals Limited (Vadodara)

Name of the Person (Designation):

Mr. Kiran (Senior Executive)

Contact Number:

91-9833492473

Since how long known:

3 Years

Maximum limit dealt:

Rs. 20.000 Million (Monthly)

Experience:

Product Quality

Delivery Behaviour

Overall

Good

Good

Good

Remark

We had a word with Mr. Kiran (Senior Executive) the subject company have very good track record with their customer.

 

·         Aarti Drugs Limited

·         Biotavia Pharma Limited

·         Cadila Pharmaceutical Limited

·         Cipla Limited

·         Elder Pharma Limited

·         Ferring Pharmaceutical Limited

·         Intas Pharmaceutical Limited

·         Mankind Pharma Limited

 

 

No. of Employees :

200 (Approximately)

 

 

Bankers :

Bank Name:

Andhra Bank

Branch:

SSI Mallapur, Mallapur, Hyderabad - 500076, Andhra Pradesh, India

Person Name (with Designation):

Not Divulged

Contact Number:

91-40-27178024 (The Number is not Working)

Name of Account Holder:

Not Divulged

Account Number:

Not Divulged

Account Since (Date/ Year of A/c Opening):

Not Divulged

Average Balance Maintained (Optional):

Not Divulged

Credit Facilities Enjoyed (CC/OD/Term Loan):

Not Divulged

Account Operation:

Not Divulged

Remarks:

Not Divulged

 

·         Andhra Bank

SME Mallapur, Mallapur, Hyderabad - 500076, Andhra Pradesh, India

 

·         Canara Bank

 

 

Facilities :

SECURED LOANS

31.03.2014

(Rs. In Million)

31.03.2013

(Rs. In Million)

LONG-TERM BORROWINGS

 

 

Term Loan

 

 

Canara Bank

25.116

17.697

 

 

 

SHORT TERM BORROWINGS

 

 

Cash Credit

(Cash credit facilities secured by way of hypothecation of stocks and book debts of the company)

56.198

49.496

Total

81.314

67.193

 

Auditors :

 

Name :

Ashwani K Gupta and Associates

Chartered Accountants

Address :

1105, Sector21 B, Chandigarh-160022, Punjab, India

Income-tax PAN of auditor or auditor's firm :

AACFA3955A

 

 

Memberships :

--

 

 

Collaborators :

--

 

 

Associates/Subsidiaries :

·         Crescent Formulation Private Limited

 


 

CAPITAL STRUCTURE

 

AS ON 31.03.2014

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

4500000

Equity Shares

Rs. 10/- each

Rs. 45.000 Million

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

4157900

Equity Shares

Rs. 10/- each

Rs. 41.579 Million

 

 

 

 

 


 

FINANCIAL DATA

[all figures are in Rupees Million]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2014

31.03.2013

31.03.2012

I.              EQUITY AND LIABILITIES

 

 

 

(1)Shareholders' Funds

 

 

 

(a) Share Capital

41.579

40.000

40.000

(b) Reserves & Surplus

82.062

65.726

53.749

(c) Money received against share warrants

0.000

0.000

0.000

 

 

 

 

(2) Share Application money pending allotment

8.587

12.154

0.000

Total Shareholders’ Funds (1) + (2)

132.228

117.880

93.749

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) Long-term borrowings

48.868

39.744

55.149

(b) Deferred tax liabilities (Net)

10.915

9.553

8.102

(c) Other long term liabilities

0.000

0.000

0.000

(d) long-term provisions

0.000

0.000

0.000

Total Non-current Liabilities (3)

59.783

49.297

63.251

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short term borrowings

56.198

49.496

42.962

(b) Trade payables

82.885

37.972

17.406

(c) Other current liabilities

24.766

22.912

34.014

(d) Short-term provisions

4.146

3.358

2.516

Total Current Liabilities (4)

167.995

113.738

96.898

 

 

 

 

TOTAL

360.006

280.915

253.898

 

 

 

 

II.            ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

152.331

142.925

140.872

(ii) Intangible Assets

1.200

1.200

0.000

(iii) Capital work-in-progress

0.000

0.000

0.000

(iv) Intangible assets under development

0.000

0.000

0.000

(b) Non-current Investments

0.000

0.000

0.000

(c) Deferred tax assets (net)

0.000

0.000

0.000

(d)  Long-term Loan and Advances

0.000

0.000

0.000

(e) Other Non-current assets

0.000

0.000

0.000

Total Non-Current Assets

153.531

144.125

140.872

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

0.000

0.000

0.000

(b) Inventories

81.823

61.817

46.051

(c) Trade receivables

98.847

53.932

44.244

(d) Cash and cash equivalents

1.036

0.291

0.177

(e) Short-term loans and advances

3.164

2.707

2.510

(f) Other current assets

21.605

18.043

20.044

Total Current Assets

206.475

136.790

113.026

 

 

 

 

TOTAL

360.006

280.915

253.898

 

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

 

31.03.2014

31.03.2013

31.03.2012

 

SALES

 

 

 

 

 

Income

462.807

301.303

252.935

 

 

Other Income

0.524

2.843

0.400

 

 

TOTAL                                     (A)

463.331

304.146

253.335

 

 

 

 

 

Less

EXPENSES

 

 

 

 

 

Cost of Materials Consumed

348.652

210.214

146.850

 

 

Changes in inventories of finished goods, work-in-progress and Stock-in-Trade

(2.742)

2.558

21.080

 

 

Employees benefits expense

24.838

18.812

17.494

 

 

Other expenses

48.128

34.171

29.942

 

 

Prior Period Expenses

0.000

0.000

0.195

 

 

TOTAL                                     (B)

418.876

265.755

215.561

 

 

 

 

 

 

PROFIT BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION (A-B)     (C)

44.455

38.391

37.774

 

 

 

 

 

Less

FINANCIAL EXPENSES                                    (D)

15.654

14.363

17.022

 

 

 

 

 

 

PROFIT BEFORE TAX, DEPRECIATION AND AMORTISATION (C-D)                                       (E)

28.801

24.028

20.752

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION                     (F)

8.077

7.242

7.179

 

 

 

 

 

 

PROFIT BEFORE TAX (E-F)                              (G)

20.724

16.786

13.573

 

 

 

 

 

Less

TAX                                                                  (H)

5.509

4.809

4.150

 

 

 

 

 

 

PROFIT AFTER TAX (G-H)                                (I)

15.215

11.977

9.423

 

 

 

 

 

 

Earnings Per Share (Rs.)

3.66

2.99

2.36

 

 

PARTICULARS

 

 

 

31.03.2015

Sales Turnover (Approximately)

 

 

300.000

 

 

 

(Due to received less order the sales turnover had decrease in the year 14-15)

 

The above information has been parted by Mr. Shiv Thakur (Accounts Department)

 

 

CURRENT MATURITIES OF LONG TERM DEBT DETAILS

 

Particulars

 

31.03.2014

31.03.2013

31.03.2012

Current Maturities of Long term debt

18.534

0.000

13.750

 

 

 

 

Cash Generated from Operations

NA

NA

NA

 

 

 

 

Net Cash Flow from used in Operations

NA

NA

NA

 

 

KEY RATIOS

 

 

PARTICULARS

 

 

31.03.2014

31.03.2013

31.03.2012

Net Profit Margin

(PAT / Sales)

(%)

3.29

3.98

3.73

 

 

 

 

 

Operating Profit Margin

(PBDIT/Sales)

(%)

9.61

12.74

14.93

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

5.76

5.98

5.35

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

0.16

0.14

0.14

 

 

 

 

 

Debt Equity Ratio

(Total Liability/Networth)

 

0.93

0.76

1.19

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

1.23

1.20

1.17

 

Total Liability = Short-term Debt + Long-term Debt + Current Maturities of Long-term debts

 

 

FINANCIAL ANALYSIS

[all figures are in Rupees Million]

 

DEBT EQUITY RATIO

 

Particular

31.03.2012

31.03.2013

31.03.2014

 

(Rs. In Million)

(Rs. In Million)

(Rs. In Million)

Share Capital

40.000

40.000

41.579

Reserves & Surplus

53.749

65.726

82.062

Money received against share warrants

0.000

0.000

0.000

Share Application money pending allotment

0.000

12.154

8.587

Net worth

93.749

117.880

132.228

 

 

 

 

Long-term borrowings

55.149

39.744

48.868

Short term borrowings

42.962

49.496

56.198

CURRENT MATURITIES OF LONG-TERM DEBTS

13.750

0.000

18.534

Total borrowings

111.861

89.240

123.600

Debt/Equity ratio

1.193

0.757

0.935

 

 

 

YEAR-ON-YEAR GROWTH

 

Year on Year Growth

31.03.2012

31.03.2013

31.03.2014

 

(Rs. In Million)

(Rs. In Million)

(Rs. In Million)

Sales

252.935

301.303

462.807

 

 

19.123

53.602

 

 

 

NET PROFIT MARGIN

 

Net Profit Margin

31.03.2012

31.03.2013

31.03.2014

 

(Rs. In Million)

(Rs. In Million)

(Rs. In Million)

Sales

252.935

301.303

462.807

Profit

9.423

11.977

15.215

 

3.73%

3.98%

3.29%

 

 


LOCAL AGENCY FURTHER INFORMATION

 

Sr. No.

Check list by info agents

Available in Report

(Yes/No)

1

Year of establishment

Yes

2

Constitution of the entity -Incorporation details

Yes

3

Locality of the entity

Yes

4

Premises details

No

5

Buyer visit details

--

6

Contact numbers

Yes

7

Name of the person contacted

Yes

8

Designation of contact person

Yes

9

Promoter’s background

Yes

10

Date of Birth of Proprietor / Partners / Directors

Yes

11

Pan Card No. of Proprietor / Partners

No

12

Voter Id Card No. of Proprietor / Partners

No

13

Type of business

Yes

14

Line of Business

Yes

15

Export/import details (if applicable)

Yes

16

No. of employees

Yes

17

Details of sister concerns

Yes

18

Major suppliers

Yes

19

Major customers

Yes

20

Banking Details

Yes

21

Banking facility details

Yes

22

Conduct of the banking account

Yes

23

Financials, if provided

Yes

24

Capital in the business

Yes

25

Last accounts filed at ROC, if applicable

Yes

26

Turnover of firm for last three years

Yes

27

Reasons for variation <> 20%

Yes

28

Estimation for coming financial year

No

29

Profitability for last three years

Yes

30

Major shareholders, if available

Yes

31

External Agency Rating, if available

Yes

32

Litigations that the firm/promoter involved in

--

33

Market information

--

34

Payments terms

Yes

35

Negative Reporting by Auditors in the Annual Report

No

 

 

 

 

INDEX OF CHARGES

 

S.NO.

CHARGE ID

DATE OF CHARGE CREATION/MODIFICATION

CHARGE AMOUNT SECURED

CHARGE HOLDER

ADDRESS

SERVICE REQUEST NUMBER (SRN)

1

10527569

02/09/2014

154,300,000.00

ANDHRA BANK

SME, MALLAPUR, HYDERABAD, HYDERABAD-500076, TELANGANA , INDIA

C31028459

2

10304578

30/08/2011

3,000,000.00

DIRECTOR OF INDUSTRIES HIMACHAL PRADESH

THROUGH DY. DIRECTOR OF INDUSTRIES,, SINGLE WINDO
W CLEARANCE AGENCY (SWCA), BADDI- 174103, HIMACHAL PRADESH
, INDIA

B19774975

3

90121810

15/06/2004

559,565.00

ICICI BANK LIMITED

ICICI TOWERS BANDRA KURLA COMPLEX, MUMBAI, MAHARAS
HTRA, INDIA

-

 

 

UNSECURED LOANS

 

PARTICULARS

31.03.2014

(Rs. In Million)

31.03.2013

(Rs. In Million)

LONG-TERM BORROWINGS

 

 

Unsecured Loans from NBFC

1.644

2.939

Other loans

22.108

19.108

 

 

 

Total

23.752

22.047

 

 

INDUSTRIAL SCENARIO:

 

The Indian Pharmaceutical Industry is the third largest in the world and is growing at about 8% annually and is expected to touch USD 20 billion by 2015.The present domestic market is controlled to the extent of about 70% by top 250 companies and raise to the level of feasible turnover, These units need to improve the expertise to meet the challenges of technological developments by suitable training and have adequate finance for technological up-gradation and adoption of good manufacturing practices (GMP) to meet global quality standards.

 


 

FUTURE OUTLOOK:

 

The Company with its world class and GMP compliant manufacturing facilities, qualified and experienced team of professionals, continued enquiries from leading domestic Companies for using the infrastructure hopes to improve its turnover in the coming years to the satisfaction of all stakeholders. The Company is aiming to capture the overseas market in third world countries and product registration with several countries like Sri Lanka. Vietnam, Myanmar is under process. The Company is in touch with the prospective buyers from these countries. One product Ambitext 30 was registered with Sri Lanka Govt. and exports commenced in 2014-15.


FIXED ASSETS:

 

Tangible Assets

 

·         Land

·         Buildings

·         Plant and Equipment

·         Furniture and Fixtures

·         Vehicles

·         Office Equipment

·         Computer

 

CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                           None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                        None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                        None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

 

Unit

Indian Rupees

US Dollar

1

Rs. 65.25

UK Pound

1

  Rs. 102.25

Euro

1

Rs. 72.20

 

 

INFORMATION DETAILS

 

Information Gathered by :

MAN

 

 

Analysis Done by :

KAS

 

 

Report Prepared by :

IND

 


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

5

PAID-UP CAPITAL

1~10

5

OPERATING SCALE

1~10

6

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

6

--PROFITABILIRY

1~10

5

--LIQUIDITY

1~10

5

--LEVERAGE

1~10

5

--RESERVES

1~10

5

--CREDIT LINES

1~10

5

--MARGINS

-5~5

--

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

YES

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

DEFAULTER

 

 

--RBI

YES/NO

NO

--EPF

YES/NO

NO

TOTAL

 

47

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                  Payment record (10%)

Credit history (10%)                   Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

--

NB

                                       New Business

 

--

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.